Solstas: Quest Diagnostics boosts 2014 guidance after closing $570M Solstas acquisition

Now that Quest Diagnostics' $570 million acquisition of Solstas Lab Partners Group is a done deal, the company's 2014 financial outlook has suddenly grown far more optimistic.